Cargando…

Molecular Genetic Regulation of Slc30a8/ZnT8 Reveals a Positive Association With Glucose Tolerance

Zinc transporter 8 (ZnT8), encoded by SLC30A8, is chiefly expressed within pancreatic islet cells, where it mediates zinc (Zn(2+)) uptake into secretory granules. Although a common nonsynonymous polymorphism (R325W), which lowers activity, is associated with increased type 2 diabetes (T2D) risk, rar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Ryan K., Hu, Ming, Chabosseau, Pauline L., Cane, Matthew C., Meur, Gargi, Bellomo, Elisa A., Carzaniga, Raffaella, Collinson, Lucy M., Li, Wen-Hong, Hodson, David J., Rutter, Guy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995240/ https://www.ncbi.nlm.nih.gov/pubmed/26584158 http://dx.doi.org/10.1210/me.2015-1227

Ejemplares similares

Hypoxia lowers SLC30A8/ZnT8 expression and free cytosolic Zn(2+) in pancreatic beta cells
por: Gerber, Philipp A., et al.
Publicado: (2014)

The Zinc Transporter Slc30a8/ZnT8 Is Required in a Subpopulation of Pancreatic α-Cells for Hypoglycemia-induced Glucagon Secretion
por: Solomou, Antonia, et al.
Publicado: (2015)

Over-expression of Slc30a8/ZnT8 selectively in the mouse α cell impairs glucagon release and responses to hypoglycemia
por: Solomou, Antonia, et al.
Publicado: (2016)

Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients
por: Skärstrand, H, et al.
Publicado: (2015)

ZnT8 Loss of Function Mutation Increases Resistance of Human Embryonic Stem Cell-Derived Beta Cells to Apoptosis in Low Zinc Condition
por: Sui, Lina, et al.
Publicado: (2023)

Structure/Function Analysis of human ZnT8 (SLC30A8): A Diabetes Risk Factor and Zinc Transporter
por: Daniels, Mark J., et al.
Publicado: (2020)

Glucose Regulates Free Cytosolic Zn(2+) Concentration, Slc39 (ZiP), and Metallothionein Gene Expression in Primary Pancreatic Islet β-Cells
por: Bellomo, Elisa A., et al.
Publicado: (2011)

Lack of ZnT8 protects pancreatic islets from hypoxia- and cytokine-induced cell death
por: Karsai, Maria, et al.
Publicado: (2022)

Loss of ZnT8 function protects against diabetes by enhanced insulin secretion
por: Dwivedi, Om Prakash, et al.
Publicado: (2019)

A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes
por: Wenzlau, Janet M., et al.
Publicado: (2008)

ZnT8 Haploinsufficiency Impacts MIN6 Cell Zinc Content and β-Cell Phenotype via ZIP-ZnT8 Coregulation
por: Lawson, Rebecca, et al.
Publicado: (2019)

Genetic, Functional, and Immunological Study of ZnT8 in Diabetes
por: Huang, Qiong, et al.
Publicado: (2019)

Development of an immunoassay for the simultaneous detection of GADA and ZnT8A in autoimmune diabetes using a ZnT8/GAD65 chimeric molecule
por: Trabucchi, Aldana, et al.
Publicado: (2023)

Insulin Storage and Glucose Homeostasis in Mice Null for the Granule Zinc Transporter ZnT8 and Studies of the Type 2 Diabetes–Associated Variants
por: Nicolson, Tamara J., et al.
Publicado: (2009)

Insights into the Dynamics of the Human Zinc Transporter ZnT8 by MD Simulations
por: Sala, Davide, et al.
Publicado: (2021)

Three-dimensional structure of β-cell-specific zinc transporter, ZnT-8, predicted from the type 2 diabetes-associated gene variant SLC30A8 R325W
por: Weijers, Rob NM
Publicado: (2010)

Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases
por: Howson, J. M. M., et al.
Publicado: (2012)

Association of Zinc Transporter-8 Autoantibody (ZnT8A) with Type 1 Diabetes Mellitus
por: Bhatty, Afreen, et al.
Publicado: (2020)

ZnT8 Is a Major CD8(+) T Cell–Recognized Autoantigen in Pediatric Type 1 Diabetes
por: Énée, Émmanuelle, et al.
Publicado: (2012)

SLC30A3 (ZnT3) Oligomerization by Dityrosine Bonds Regulates Its Subcellular Localization and Metal Transport Capacity
por: Salazar, Gloria, et al.
Publicado: (2009)

Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease
por: Zhang, Xiuli, et al.
Publicado: (2020)

Cryo-EM structures of human ZnT8 in both outward- and inward-facing conformations
por: Xue, Jing, et al.
Publicado: (2020)

The Functions of ZIP8, ZIP14, and ZnT10 in the Regulation of Systemic Manganese Homeostasis
por: Winslow, James W.W., et al.
Publicado: (2020)

Zinc transporter 8 (ZnT8) autoantibody prevalence in black South African participants with type 1 diabetes
por: Bhola, Sureka, et al.
Publicado: (2021)

SAT064 Establishment And Initial Characterization Of Two Parallel Targeted Human ZnT8 Knock-in Murine Lines For Studying The Type 2 Diabetes Risk Variant At SNP rs13266634 Of The ZnT8 Gene
por: Wang, Janice C, et al.
Publicado: (2023)

Mice harboring the human SLC30A8 R138X loss-of-function mutation have increased insulin secretory capacity
por: Kleiner, Sandra, et al.
Publicado: (2018)

Prevalence of ZnT8 Antibody in Turkish Children and Adolescents with New Onset Type 1 Diabetes
por: Elmaoğulları, Selin, et al.
Publicado: (2018)

Zinc Transporter 8 (ZnT8) Expression Is Reduced by Ischemic Insults: A Potential Therapeutic Target to Prevent Ischemic Retinopathy
por: DeNiro, Michael, et al.
Publicado: (2012)

Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison’s disease
por: Fichna, Marta, et al.
Publicado: (2016)

Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus
por: Faccinetti, Natalia I., et al.
Publicado: (2017)

The C‐terminal cytosolic domain of the human zinc transporter ZnT8 and its diabetes risk variant
por: Parsons, Douglas S., et al.
Publicado: (2018)

Probing the Structure and Function of the Cytosolic Domain of the Human Zinc Transporter ZnT8 with Nickel(II) Ions
por: Catapano, Maria Carmen, et al.
Publicado: (2021)

High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes
por: Jia, Xiaofan, et al.
Publicado: (2021)

Cooperative Functions of ZnT1, Metallothionein and ZnT4 in the Cytoplasm Are Required for Full Activation of TNAP in the Early Secretory Pathway
por: Fujimoto, Shigeyuki, et al.
Publicado: (2013)

Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β-cell are associated with glucose intolerance in humans and mice
por: Mehta, Zenobia B., et al.
Publicado: (2016)

ZnT8-Reactive T Cells Are Weakly Pathogenic in NOD Mice but Can Participate in Diabetes Under Inflammatory Conditions
por: Nayak, Deepak K., et al.
Publicado: (2014)

Clinical Utility and Outcome Prediction of Early ZnT8-IgG Testing and Titer in Type 1 Diabetes
por: Dahl, Amanda R., et al.
Publicado: (2023)

Expression of concern: Zinc transporter 8 (ZnT8) expression is reduced by ischemic insults: A potential therapeutic target to prevent ischemic retinopathy
Publicado: (2019)

Angiotensin II Requires Zinc and Downregulation of the Zinc Transporters ZnT3 and ZnT10 to Induce Senescence of Vascular Smooth Muscle Cells
por: Patrushev, Nikolay, et al.
Publicado: (2012)

Altered Expression of ZnT10 in Alzheimer's Disease Brain
por: Bosomworth, Helen J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_noiief5pqem0s62i2svgoij7ng